MREO MREO · 2 articles Earnings August 12, 2026 Earnings Mereo BioPharma Licenses Alvelestat to Sentynl in Deal Worth Up to $475 Million Other Coverage August 11, 2026 Deals Sentynl Therapeutics to Acquire Alvelestat Rights in $475 Million Asset Deal